These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9129871)

  • 41. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of calcium antagonists on exercise tests.
    Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma endothelin-1 concentrations in patients with coronary artery disease during stress test before and after nisoldipine administration.
    Letizia C; Barillà F; Cerci S; De Ciocchis A; Coassin S; Mastroianni MA; D'Ambrosio C; Campa PP; Scavo D
    Acta Cardiol; 1996; 51(2):165-72. PubMed ID: 8742913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Nisoldipine in comparison with long-term nitrates].
    Eber B; Schumacher M; Zweiker R; Pokan R; Klein W
    Acta Med Austriaca; 1992; 19(5):137-9. PubMed ID: 1298142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
    Kobrin I; Bieska G; Charlon V; Lindberg E; Pordy R
    Cardiology; 1998; 89 Suppl 1():23-32. PubMed ID: 9570426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology.
    Deanfield JE
    Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():239-42. PubMed ID: 9800053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nisoldipine: a new dihydropyridine calcium-channel blocker.
    Mitchell J; Frishman W; Heiman M
    J Clin Pharmacol; 1993 Jan; 33(1):46-52. PubMed ID: 8429113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
    Deedwania PC; Cheitlin MD; Das SK; Pool PE; Singh JB; Pasternak RC
    Clin Cardiol; 1993 Aug; 16(8):599-602. PubMed ID: 8370191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silent myocardial ischemia: improvement with nisoldipine therapy.
    Glasser SP; Arce-Weston B; Clark PI
    South Med J; 1989 Jan; 82(1):32-4, 46. PubMed ID: 2643167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute effects of nisoldipine, propranolol, and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study.
    De Caprio L; Papa M; Acanfora D; Abete P; Gallucci F; Covelluzzi F; Cicatiello AM; Rengo F
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):325-30. PubMed ID: 1697390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
    Grönefeld G; Bernhardt J; Schneider W
    Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of nisoldipine on the total ischaemic burden: the results of the ROCKET study.
    Fox K; Pool J; Vos J; Lubsen J
    Eur Heart J; 1991 Dec; 12(12):1283-7. PubMed ID: 1778193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical pharmacokinetics of vasodilators. Part I.
    Kirsten R; Nelson K; Kirsten D; Heintz B
    Clin Pharmacokinet; 1998 Jun; 34(6):457-82. PubMed ID: 9646008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DEFIANT-II: a study of nisoldipine CC after myocardial infarction. Doppler flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy investigators.
    Hall R
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():881. PubMed ID: 9126677
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of nisoldipine on myocardial ischemia during exercise and during daily activity.
    Tzivoni D; Banai S; Botvin S; Zilberman A; Weiss TA; Gavish A; Medina A; Benhorin J; Rogel S; Caspi A
    Am J Cardiol; 1991 Mar; 67(7):559-64. PubMed ID: 2000786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
    Elliott HL; Meredith PA; McNally C; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):379-85. PubMed ID: 1777376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.